The partnership deal closed with Curium last year marks the most important milestone for
- The acceptance illustrates the strong progress being made in developing uTRACE, CEO
Read the full article at biostock.se:
https://www.biostock.se/en/2024/04/curasight-gets-green-light-from-ema-in-phase-ii-prostate-cancer-trial/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se
https://news.cision.com/curasight/r/biostock--curasight-gets-green-light-from-ema-in-phase-ii-prostate-cancer-trial,c3964553
(c) 2024 Cision. All rights reserved., source